Ultragenyx Pharmaceutical Company

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Investors

Headquarters: Novato, California, United States
Funding Status: IPO
Employee Number: 501-1000
Estimated Revenue: $10M to $50M
Technology: Immunotherapy
Founded Date: 2010
Industry: PharmTech
Register and Claim Ownership